Cancer dormancy. VII. A regulatory role for CD8+ T cells and IFN-γ in establishing and maintaining the tumor-dormant state

Journal of Immunology

Volumn 162, Issue 5, 1999, Pages 2842-2849

  Farrar, J David ^a,b,d   Katz, Kathy H ^b   Windsor, Jana ^b   Thrush, Gerald ^c   Scheuermann, Richard H ^b   Uhr, Jonathan W ^b   Street, Nancy E ^b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c CALIFORNIA STATE UNIVERSITY   (United States)

^d WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; IMMUNOGLOBULIN; MONOCLONAL ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; B CELL LYMPHOMA; CANCER INHIBITION; CANCER THERAPY; CELL CYCLE; CELLULAR IMMUNITY; CONTROLLED STUDY; FEMALE; HUMORAL IMMUNITY; INTERFERON PRODUCTION; MOUSE; NONHUMAN; PASSIVE IMMUNIZATION; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION;

ANIMALS; APOPTOSIS; CD8-POSITIVE T-LYMPHOCYTES; CELL CYCLE; FEMALE; IMMUNIZATION; IMMUNOGLOBULIN G; INTERFERON TYPE II; LYMPHOMA, B-CELL; MICE; MICE, INBRED BALB C; MICE, SCID; NEOPLASMS, EXPERIMENTAL;

EID: 0033105809     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Wilson, A., A. J. T. George, C. A. King, and F. K. Stevenson. 1990. Recognition of a B cell lymphoma by anti-idiotypic T cells. J. Immunol. 145:3937.
2. Campbell, M. J., W. Carroll, S. Kon, K. Thielemans, J. B. Rothbard, S. Levy, and R. Levy. 1987. Idiotype vaccination against murine B cell lymphoma: humoral and cellular responses elicited by tumor-derived immunoglobulin M and its molecular subunits. J. Immunol. 139:2825.
3. Lauritzsen, G. F., S. Weiss, Z. Dembic, and B. Bogen. 1994. Naive idiotype-specific CD4+ T cells and immunosurveillance of B-cell tumors. Proc. Natl. Acad. Sci. USA 91:5700.
4. Kwak, L. W., M. J. Campbell, D. K. Czerwinski, S. Hart, R. A. Miller, and R. Levy. 1992. Induction of immune responses in patients with B-cell lymphoma against the surface-immunoglobulin idiotype expressed by their tumors. N. Engl. J. Med. 327:1209.
5. 1 lymphoma. Cancer Res. 51:5045.
6. Yefenof, E., L. J. Picker, R. H. Scheuermann, T. Tucker, E. S. Vitetta, and J. W. Uhr. 1993. Cancer dormancy: isolation and characterization of dormant lymphoma cells. Proc. Natl. Acad. Sci. USA 90:1829.
7. Yefenof, E., L. J. Picker, R. H. Scheuermann, E. S. Vitetta, N. E. Street, T. Tucker, and J. W. Uhr. 1993. Induction of B cell tumor dormancy by anti-idiotypic antibodies. Curr. Opin. Immunol. 5:740.
8. 1 after dormancy is established. Blood 89:4425.
9. George, A. J. T., S. G. Folkard, T. J. Hamblin, and F. K. Stevenson. 1988. Idiotypic vaccination as a treatment for a B cell lymphoma. J. Immunol. 141: 2168.
10. 1. J. Immunol. 138:628.
11. Scheuermann, R. H., E. Racila, T. Tucker, E. Yefenof, N. E. Street, E. S. Vitetta, L. J. Picker, and J. W. Uhr. 1994. Lyn tyrosine kinase signals cell cycle arrest but not apoptosis in B-lineage lymphoma cells. Proc. Natl. Acad. Sci. USA 91:4048.
12. Racila, E., R. H. Scheuermann, L. J. Picker, E. Yefenof, T. Tucker, W. Chang, R. Marches, N. E. Street, E. S. Vitetta, and J. W. Uhr. 1995. Tumor dormancy and cell signaling. II. Antibody as an agonist in inducing dormancy of a B cell lymphoma in SCID mice. J. Exp. Med. 181:1539.
13. + T cells in tumor resistance against major histocompatibility complex class II molecule negative plasmacytoma cells. Cell. Immunol. 148:177.
14. Lauritzsen, G. F., and B. Bogen. 1991. Idiotype-specific, major histocompatibility complex restricted T cells are of both Th1 and Th2 type. Scand. J. Immunol. 33:647.
15. + cytotoxic T-lymphocyte activation in mice. Cancer Res. 56:5005.
16. Khazaie, K., S. Prifti, P. Beckhove, A. Griesbach, S. Russel, M. Collins, and V. Schirrmacher. 1994. Persistence of dormant tumor cells in the bone marrow of tumor cell-vaccinated mice correlates with long-term immunological protection. Proc. Natl. Acad. Sci. USA 91:7430.
17. Marsili, M. A., M. K. Robinson, G. A. Truitt, and E. F. Wheelock. 1983. Elimination of L5178Y cells from tumor-dormant DBA/2 mice by specific active immunotherapy. Cancer Res. 43:15.
18. Marsili, M. A., M. K. Robinson, G. A. Truitt, and E. F. Wheelock. 1983. Cytotoxic T lymphocytes in DBA/2 mice harboring L5178Y cells in a tumor dormant state. Cancer Immunol. Immunother. 16:59.
19. Flamand, V., T. Sornasse, K. Thielemans, C. Demanet, M. Bakkus, H. Bazin, O. Tielemans, J. Leo, J. Urbain, and M. Moser. 1994. Murine dendritic cells pulsed in vitro with tumor antigen induce tumor resistance in vivo. Eur. J. Immunol. 24:605.
20. King, C. A., M. R. Wills, T. J. Hamblin, and F. K. Stevenson. 1993. Idiotypic IgM on a B-cell surface requires processing for recognition by anti-idiotypic T cells. Cell. Immunol. 147:411.
21. + T cells into subpopulation with distinct cytokine profiles. J. Immunol. 155:2928.
22. Snapper, C., and W. E. Paul. 1987. Interferon-γ and B cell stimulatory factor-1 reciprocally regulate Ig isotype production. Science 236:944.
23. Berton, M. T., J. W. Uhr, and E. S. Vitetta. 1989. Synthesis of germ-line γ1 immunoglobulin heavy-chain transcripts in resting B cells: induction by interleukin 4 and inhibition by interferon γ. Proc. Natl. Acad. Sci. USA 86:2829.
24. Finkelman, F. D., J. Holmes, I. M. Katona, J. J. Urban, M. P. Beckmann, L. S. Park, K. A. Schooley, R. L. Coffman, T. R. Mosmann, and W. E. Paul. 1990. Lymphokine control of in vivo immunoglobulin isotype selection. Annu. Rev. Immunol. 8:303.
25. + effector cells default to the Th2 pathway in interferon γ-deficient mice infected with Leishmania major. J. Exp. Med. 179:1367.
26. Huang, S., W. Hendriks, A. Althage, S. Hemmi, H. Bluethmann, R. Kamijo, J. Vilcek, R. M. Zinkernagel, and M. Aguet. 1993. Immune response in mice that lack the IFN-γ receptor. Science 259:1742.
27. Agrewala, J. N., G. P. Raghava, and G. C. Mishra. 1993. Measurement and computation of murine interleukin-4 and interferon-γ by exploiting Ihe unique abilities of these lymphokines to induce the secretion of IgG1 and IgG2a. J. Immunoassay 14:83.
28. Taylor, C. E., P. J. Baker, T. Hraba, P. Stashak, and M. B. Fauntleroy. 1994. Effects of interferon γ on the antibody response to Pseudomonas aeruginosa lipopolysaccharide in mice. Immunobiology 192:106.
29. Agrewala, J. N., and G. C. Mishra. 1995. A 38-kDa antigen of Mycobacterium tuberculosis predominantly induces the secretion of interleukin-2, interferon-γ and IgG2a antibodies. Microbiol. Immunol. 39:801.
30. Waki, S., S. Uehara, K. Kanbe, H. Nariuch, and M. Suzuki. 1995. Interferon-γ and the induction of protective IgG2a antibodies in non-lethal Plasmodium berghei infections of mice. Parasite Immunol. 17:503.
31. Raz, E., H. Tighe, Y. Sato, M. Corr, J. A. Dudler, M. Roman, S. L. Swain, H. L. Spiegelberg, and D. A. Carson. 1996. Preferential induction of a Th1 immune response and inhibition of specific IgE antibody formation by plasmid DNA immunization. Proc. Natl. Acad. Sci. USA 93:5141.
32. Dyke, R. J., H. McBride, A. J. T. George, T. J. Hamblin, and F. K. Stevenson. 1991. Idiotypic vaccination against B-cell lymphoma leads to dormant tumor. Cell. Immunol. 132:70.
33. Varkila, K., R. Chatelain, L. M. C. C. Leal, and R. L. Coffman. 1993. Reconstitution of C. B-17 scid mice with BALB/c T cells initiates a T helper type-1 response and renders them capable of healing Leishmania major infection. Eur. J. Immunol. 23:262.
34. Kos, F. J., and E. G. Engelman. 1995. Requirement for natural killer cells in the induction of cytotoxic T cells. J. Immunol. 155:578.
35. Kagi, D., F. Vignaux, B. Ledermann, K. Burki, V. Depraetere, S. Nagata, H. Hengartner, and P. Golstein. 1994. Fas and perform pathways as major mechanisms of T cell-mediated cytotoxicity. Science 265:528.
36. Chace, J. H., J. S. Codery, and E. H. Field. 1994. Effect of anti-CD4 on CD4 subsets. I. Anti-CD4 preferentially deletes resting, naive CD4 cells and spares activated CD4 cells. J. Immunol. 152:405.
37. Wigginton, J. M., D. B. Kuhns, T. C. Back, M. J. Brunda, R. H. Wiltrout, and G. W. Cox. 1996. Interleukin 12 primes macrophages for nitric oxide production in vivo and restores depressed nitric oxide production by macrophages from tumor-bearing mice: implications for the anlitumor activity of interleukin 12 and/or interleukin 2. Cancer Res. 56:1131.
38. + cytotoxic T lymphocytes and macrophages. Immunobiology 186:214.
39. + T lymphocytes. J. Immunol. 151:2444.
40. Kaplan, D. H., V. Shankaran, A. S. Dighe, E. Stockert, M. Aguet, L. J. Old, and R. D. Schreiber. 1998. Demonstration of an interferon γ-dependent tumor surveillance system in immunocompetent mice. Proc. Natl. Acad. Sci. USA 95:7556.
41. Bromberg, J. F., C. M. Horvath, Z. Wen, R. D. Schreiber, and J. E. Darnell. 1996. Transcriptionally active Stat1 is required for the antiproliferative effects of both interferon α and interferon γ. Proc. Natl. Acad. Sci. USA 93:7673.
42. Trubiani, O., D. Bosco, and R. DiPrimio. 1994. Interferon-γ (IFN-γ) induces programmed cell death in differentiated human leukemic B cell lines. Exp. Cell Res. 215:23.